1. Home
  2. BCSF vs MGTX Comparison

BCSF vs MGTX Comparison

Compare BCSF & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bain Capital Specialty Finance Inc.

BCSF

Bain Capital Specialty Finance Inc.

HOLD

Current Price

$12.20

Market Cap

838.7M

Sector

Finance

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$11.71

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCSF
MGTX
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
838.7M
909.1M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
BCSF
MGTX
Price
$12.20
$11.71
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$14.00
$24.57
AVG Volume (30 Days)
386.0K
780.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
14.61%
N/A
EPS Growth
N/A
33.02
EPS
0.05
N/A
Revenue
N/A
$81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
N/A
N/A
P/E Ratio
$240.80
N/A
Revenue Growth
N/A
144.57
52 Week Low
$11.82
$6.31
52 Week High
$15.84
$12.28

Technical Indicators

Market Signals
Indicator
BCSF
MGTX
Relative Strength Index (RSI) 37.21 69.21
Support Level $11.92 $7.10
Resistance Level $13.74 $11.85
Average True Range (ATR) 0.30 0.63
MACD -0.06 0.22
Stochastic Oscillator 27.79 83.63

Price Performance

Historical Comparison
BCSF
MGTX

About BCSF Bain Capital Specialty Finance Inc.

Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: